본문 바로가기
KERD
논문KCI 등재

대한갑상선학회 갑상선결절 진료권고안 2024

Korean Thyroid Association Management Guidelines for Patients with Thyroid Nodules 2024

2

조회

0

다운로드

2

인용

0

참고문헌

키워드

주제분류의학일반

초록

Thyroid nodules represent a prevalent condition that is detectable via palpation or ultrasound. In recent years, there has been a paradigm shift toward enhanced diagnostic precision and less aggressive therapeutic approaches, highlighting the growing necessity for tailored clinical recommendations to optimize patient outcomes. The Korean Thyroid Association (KTA) has developed guidelines for managing patients with thyroid nodules, following a comprehensive review by task force members of the relevant literature identified via electronic database searches. The recommendations are provided with a level of recommendation for each section. The guidelines encompass thyroid cancer screening in high-risk groups, appropriate diagnostic methods for thyroid nodules, role of pathologic and molecular marker testing in making a diagnosis, long-term follow-up and treatment of benign thyroid nodules, and special considerations for pregnant women. The major revisions that were made in the 2023 guidelines were the definition of high-risk groups for thyroid cancer screening, application of the revised Korean Thyroid Imaging Reporting and Data System (K-TIRADS), addition of the role of core needle biopsy and molecular marker tests, application of active surveillance in patients with low-risk papillary thyroid microcarcinoma, and updated indications for nonsurgical treatment of benign thyroid nodules. In the 2024 revision of the KTA guidelines for thyroid cancer, the evidence for some recommendations has been updated to address the tumor size in the context of active surveillance in patients with low-risk thyroid cancer and the surgical size cutoff. These evidence-based recommendations serve to inform clinical decision-making in the management of thyroid nodules, thereby facilitating the delivery of optimal and efficacious treatments to patients.

Abstract

Thyroid nodules represent a prevalent condition that is detectable via palpation or ultrasound. In recent years, there has been a paradigm shift toward enhanced diagnostic precision and less aggressive therapeutic approaches, highlighting the growing necessity for tailored clinical recommendations to optimize patient outcomes. The Korean Thyroid Association (KTA) has developed guidelines for managing patients with thyroid nodules, following a comprehensive review by task force members of the relevant literature identified via electronic database searches. The recommendations are provided with a level of recommendation for each section. The guidelines encompass thyroid cancer screening in high-risk groups, appropriate diagnostic methods for thyroid nodules, role of pathologic and molecular marker testing in making a diagnosis, long-term follow-up and treatment of benign thyroid nodules, and special considerations for pregnant women. The major revisions that were made in the 2023 guidelines were the definition of high-risk groups for thyroid cancer screening, application of the revised Korean Thyroid Imaging Reporting and Data System (K-TIRADS), addition of the role of core needle biopsy and molecular marker tests, application of active surveillance in patients with low-risk papillary thyroid microcarcinoma, and updated indications for nonsurgical treatment of benign thyroid nodules. In the 2024 revision of the KTA guidelines for thyroid cancer, the evidence for some recommendations has been updated to address the tumor size in the context of active surveillance in patients with low-risk thyroid cancer and the surgical size cutoff. These evidence-based recommendations serve to inform clinical decision-making in the management of thyroid nodules, thereby facilitating the delivery of optimal and efficacious treatments to patients.

참고문헌 (287)

  1. Moon JH, "Prevalence of thyroid nodules and their associated clinical parameters : a large-scale, multicenter-based health checkup study", Korean J Intern Med, 33(4), pp.753~762 (2018)
  2. Parsa AA, "Thyroid nodules", pp.1~11 (2018), Springer
  3. Gnarini VL, "Very high prevalence of ultrasound thyroid scan abnormalities in healthy volunteers in Modena, Italy", J Endocrinol Invest, 36(9), pp.722~728 (2013)
  4. Oh EY, "Prevalence of thyroid nodules and cancer detected by ultrasonography in healthy Korean adults : clinical features and the risk for malignancy", J Korean Thyroid Assoc, 3(2), pp.142~148 (2010)
  5. Marqusee E, "Usefulness of ultrasonography in the management of nodular thyroid disease", Ann Intern Med, 133(9), pp.696~700 (2000)
  6. Hagag P, "Role of ultrasound-guided fine-needle aspiration biopsy in evaluation of nonpalpable thyroid nodules", Thyroid, 8(11), pp.989~995 (1998)
  7. Ha EJ, "2021 Korean Thyroid Imaging Reporting and Data System and imaging-based management of thyroid nodules : Korean Society of Thyroid Radiology consensus statement and recommendations", Korean J Radiol, 22(12), pp.2094~2123 (2021)
  8. Kim WB, "Management guidelines for patients with thyroid nodules and thyroid cancer", J Korean Endocr Soc, 22(3), pp.157~187 (2007)
  9. Yi KH, "Revised Korean Thyroid Association management guidelines for patients with thyroid nodules and thyroid cancer", J Korean Thyroid Assoc, 3(2), pp.65~96 (2010)
  10. Haugen BR, "2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer : the American Thyroid Association guidelines task force on thyroid nodules and differentiated thyroid cancer", Thyroid, 26(1), pp.1~133 (2016)
  11. Yi KH, "The revised 2016 Korean Thyroid Association guidelines for thyroid nodules and cancers : differences from the 2015 American Thyroid Association guidelines", Endocrinol Metab(Seoul), 31(3), pp.373~378 (2016)
  12. Yi KH, "2016 revised Korean Thyroid Association management guidelines for patients with thyroid nodules and thyroid cancer", Int J Thyroidol, 9, pp.59~126 (2016)
  13. Jung CK, "2019 practice guidelines for thyroid core needle biopsy : a report of the Clinical Practice Guidelines Development Committee of the Korean Thyroid Association", J Pathol Transl Med, 54(1), pp.64~86 (2020)
  14. Kim JH, "2017 thyroid radiofrequency ablation guideline : Korean Society of Thyroid Radiology", Korean J Radiol, 19(4), pp.632~655 (2018)
  15. Orloff LA, "Radiofrequency ablation and related ultrasound-guided ablation technologies for treatment of benign and malignant thyroid disease : an international multidisciplinary consensus statement of the American Head and Neck Society Endocrine Surgery Section with the Asia Pacific Society of Thyroid Surgery, Associazione Medici Endocrinologi, British Association of Endocrine and Thyroid Surgeons, European Thyroid Association, Italian Society of Endocrine Surgery Units, Korean Society of Thyroid Radiology, Latin American Thyroid Society, and Thyroid Nodules Therapies Association", Head Neck, 44(3), pp.633~660 (2022)
  16. Yi KH, "2016 revised Korean Thyroid Association management guidelines for patients with thyroid nodules and thyroid cancer", Int J Thyroidol, 9(2), pp.59~126 (2016)
  17. US Preventive Services Task Force, "Screening for thyroid cancer : US Preventive Services Task Force Recommendation Statement", JAMA, 317(18), pp.1882~1887 (2017)
  18. Curtis RE, "Solid cancers after bone marrow transplantation", N Engl J Med, 336(13), pp.897~904 (1997)
  19. Atlas G, "Secondary thyroid carcinoma in survivors of childhood cancer : a need to revise current screening recommendations", Clin Endocrinol(Oxf), 97(1), pp.137~139 (2022)
  20. Pacini F, "Post-Chernobyl thyroid carcinoma in Belarus children and adolescents : comparison with naturally occurring thyroid carcinoma in Italy and France", J Clin Endocrinol Metab, 82(11), pp.3563~3569 (1997)
  21. Cahoon EK, "Risk of thyroid nodules in residents of Belarus exposed to Chernobyl fallout as children and adolescents", J Clin Endocrinol Metab, 102(7), pp.2207~2217 (2017)
  22. Capezzone M, "Familial non-medullary thyroid cancer : a critical review", J Endocrinol Invest, 44(5), pp.943~950 (2021)
  23. Wells SA Jr, "Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma", Thyroid, 25(6), pp.567~610 (2015)
  24. Loh KC, "Familial nonmedullary thyroid carcinoma : a meta-review of case series", Thyroid, 7(1), pp.107~113 (1997)
  25. Wang X, "Endocrine tumours : familial nonmedullary thyroid carcinoma is a more aggressive disease : a systematic review and metaanalysis", Eur J Endocrinol, 172(6), pp.R253~R262 (2015)
  26. Lee YM, "Familial history of non-medullary thyroid cancer is an independent prognostic factor for tumor recurrence in younger patients with conventional papillary thyroid carcinoma", J Surg Oncol, 109(2), pp.168~173 (2014)
  27. Park YJ, "The long-term outcomes of the second generation of familial nonmedullary thyroid carcinoma are more aggressive than sporadic cases", Thyroid, 22(4), pp.356~362 (2012)
  28. Klubo-Gwiezdzinska J, "Results of screening in familial non-medullary thyroid cancer", Thyroid, 27(8), pp.1017~1024 (2017)
  29. Rios A, "Family screening in familial papillary carcinoma : the early detection of thyroid disease", Ann Surg Oncol, 23(8), pp.2564~2570 (2016)
  30. Lee YM, "Comparison between familial and sporadic nonmedullary thyroid carcinoma : a retrospective individual risk factor-matched cohort study", Ann Surg Oncol, 28(3), pp.1722~1730 (2021)
  31. Francis GL, "Management guidelines for children with thyroid nodules and differentiated thyroid cancer", Thyroid, 25(7), pp.716~759 (2015)
  32. Pazaitou-Panayiotou K, "Thyroid cancer in patients with hyperthyroidism", Horm Metab Res, 44(4), pp.255~262 (2012)
  33. Song Y, "Effect of Graves' disease on the prognosis of differentiated thyroid carcinoma : a meta-analysis", Endocrine, 67(3), pp.516~525 (2020)
  34. Hu X, "Cancer risk in Hashimoto's thyroiditis : a systematic review and meta-analysis", Front Endocrinol(Lausanne), 13, pp.937871~ (2022)
  35. Moon S, "Associations between Hashimoto thyroiditis and clinical outcomes of papillary thyroid cancer : a meta-analysis of observational studies", Endocrinol Metab(Seoul), 33(4), pp.473~484 (2018)
  36. Tang Q, "Association between Hashimoto thyroiditis and clinical outcomes of papillary thyroid carcinoma : a meta-analysis", PLoS One, 17(6), pp.e0269995~ (2022)
  37. Burmeister LA, "Thyroid carcinoma found at parathyroidectomy : association with primary, secondary, and tertiary hyperparathyroidism", Cancer, 79(8), pp.1611~1616 (1997)
  38. Bentrem DJ, "Is preoperative investigation of the thyroid justified in patients undergoing parathyroidectomy for hyperparathyroidism?", Thyroid, 12(12), pp.1109~1112 (2002)
  39. Cetin K, "Does primary hyperparathyroidism have an association with thyroid papillary cancer? A retrospective cohort study", World J Surg, 43(5), pp.1243~1248 (2019)
  40. Haddy N, "Thyroid adenomas and carcinomas following radiotherapy for a hemangioma during infancy", Radiother Oncol, 93(2), pp.377~382 (2009)
  41. Gatta G, "Childhood cancer survival in Europe 1999-2007 : results of EUROCARE-5--a population-based study", Lancet Oncol, 15(1), pp.35~47 (2014)
  42. Lorenz E, "Radiotherapy for childhood cancer and subsequent thyroid cancer risk : a systematic review", Eur J Epidemiol, 33(12), pp.1139~1162 (2018)
  43. Veiga LH, "A pooled analysis of thyroid cancer incidence following radiotherapy for childhood cancer", Radiat Res, 178(4), pp.365~376 (2012)
  44. Rubino C, "Long-term risk of second malignant neoplasms after neuroblastoma in childhood : role of treatment", Int J Cancer, 107(5), pp.791~796 (2003)
  45. Finke I, "Radiotherapy and subsequent thyroid cancer in German childhood cancer survivors : a nested case-control study", Radiat Oncol, 10, pp.219~ (2015)
  46. Clement SC, "Balancing the benefits and harms of thyroid cancer surveillance in survivors of childhood, adolescent and young adult cancer : recommendations from the international late effects of childhood cancer guideline harmonization group in collaboration with the PanCareSurFup Consortium", Cancer Treat Rev, 63, pp.28~39 (2018)
  47. Brander A, "Clinical versus ultrasound examination of the thyroid gland in common clinical practice", J Clin Ultrasound, 20(1), pp.37~42 (1992)
  48. Tan GH, "Solitary thyroid nodule. Comparison between palpation and ultrasonography", Arch Intern Med, 155(22), pp.2418~2423 (1995)
  49. Na DG, "Core needle biopsy of the thyroid : 2016 consensus statement and recommendations from Korean Society of Thyroid Radiology", Korean J Radiol, 18(1), pp.217~237 (2017)
  50. Gharib H, "Thyroid nodules : clinical importance, assessment, and treatment", Endocrinol Metab Clin North Am, 36(3), pp.707~735 (2007)
  51. Lau LW, "Malignancy risk of hyperfunctioning thyroid nodules compared with non-toxic nodules : systematic review and a meta-analysis", Thyroid Res, 14(1), pp.3~ (2021)
  52. Repplinger D, "Is Hashimoto's thyroiditis a risk factor for papillary thyroid cancer?", J Surg Res, 150(1), pp.49~52 (2008)
  53. Suh I, "Serum thyroglobulin is a poor diagnostic biomarker of malignancy in follicular and Hurthle-cell neoplasms of the thyroid", Am J Surg, 200(1), pp.41~46 (2010)
  54. Lee EK, "Preoperative serum thyroglobulin as a useful predictive marker to differentiate follicular thyroid cancer from benign nodules in indeterminate nodules", J Korean Med Sci, 27(9), pp.1014~1018 (2012)
  55. Youn I, "Serum thyroglobulin adds no additional value to ultrasonographic features in a thyroid malignancy", Ultrasound Q, 30(4), pp.287~290 (2014)
  56. Patell R, "Assessing the utility of preoperative serum thyroglobulin in differentiated thyroid cancer : a retrospective cohort study", Endocrine, 61(3), pp.506~510 (2018)
  57. Verbeek HH, "Calcitonin testing for detection of medullary thyroid cancer in people with thyroid nodules", Cochrane Database Syst Rev, 3(3), pp.CD010159~ (2020)
  58. de Groot JW, "Determinants of life expectancy in medullary thyroid cancer : age does not matter", Clin Endocrinol(Oxf), 65(6), pp.729~736 (2006)
  59. Elisei R, "Impact of routine measurement of serum calcitonin on the diagnosis and outcome of medullary thyroid cancer : experience in 10, 864 patients with nodular thyroid disorders", J Clin Endocrinol Metab, 89(1), pp.163~168 (2004)
  60. Hahm JR, "Routine measurement of serum calcitonin is useful for early detection of medullary thyroid carcinoma in patients with nodular thyroid diseases", Thyroid, 11(1), pp.73~80 (2001)
  61. Niccoli P, "Interest of routine measurement of serum calcitonin : study in a large series of thyroidectomized patients. The French Medullary Study Group", J Clin Endocrinol Metab, 82(2), pp.338~341 (1997)
  62. Costante G, "Predictive value of serum calcitonin levels for preoperative diagnosis of medullary thyroid carcinoma in a cohort of 5817 consecutive patients with thyroid nodules", J Clin Endocrinol Metab, 92(2), pp.450~455 (2007)
  63. Chambon G, "The use of preoperative routine measurement of basal serum thyrocalcitonin in candidates for thyroidectomy due to nodular thyroid disorders : results from 2733 consecutive patients", J Clin Endocrinol Metab, 96(1), pp.75~81 (2011)
  64. Colombo C, "Comparison of calcium and pentagastrin tests for the diagnosis and follow-up of medullary thyroid cancer", J Clin Endocrinol Metab, 97(3), pp.905~913 (2012)
  65. Vardarli I, "Diagnostic accuracy of routine calcitonin measurement for the detection of medullary thyroid carcinoma in the management of patients with nodular thyroid disease : a meta-analysis", Endocr Connect, 10(3), pp.358~370 (2021)
  66. Cheung K, "Calcitonin measurement in the evaluation of thyroid nodules in the United States : a cost-effectiveness and decision analysis", J Clin Endocrinol Metab, 93(6), pp.2173~2180 (2008)
  67. Karga H, "Changes in risk factors and tumor node metastasis stage of sporadic medullary thyroid carcinoma over 41 years, before and after the routine measurements of serum calcitonin", Metabolism, 60(5), pp.604~608 (2011)
  68. Weber T, "Preoperative calcitonin testing improves the diagnosis of medullary thyroid carcinoma in female and male patients", Eur J Endocrinol, 186(2), pp.223~231 (2022)
  69. Jassal K, "Preoperative serum calcitonin may improve initial surgery for medullary thyroid cancer in patients with indeterminate cytology", ANZ J Surg, 92(6), pp.1428~1433 (2022)
  70. Do Cao C, "SFE-AFCE-SFMN 2022 consensus on the management of thyroid nodules : initial work-up for thyroid nodules", Ann Endocrinol(Paris), 83(6), pp.380~388 (2022)
  71. Dralle H, "German Association of Endocrine Surgeons practice guideline for the surgical management of malignant thyroid tumors", Langenbecks Arch Surg, 398(3), pp.347~375 (2013)
  72. Kim PH, "Diagnostic performance of four ultrasound risk stratification systems : a systematic review and meta-analysis", Thyroid, 30(8), pp.1159~1168 (2020)
  73. Joo L, "Diagnostic performance of ultrasound-based risk stratification systems for thyroid nodules : a systematic review and meta-analysis", Endocrinol Metab(Seoul), 38(1), pp.117~128 (2023)
  74. Gharib H, "American Association of Clinical Endocrinologists, American College of Endocrinology, and Associazione Medici Endocrinologi Medical Guidelines for Clinical Practice for the Diagnosis and Management of Thyroid Nodules--2016 update", Endocr Pract, 22(5), pp.622~639 (2016)
  75. Shin JH, "Ultrasonography diagnosis and imaging-based management of thyroid nodules : revised Korean Society of Thyroid Radiology consensus statement and recommendations", Korean J Radiol, 17(3), pp.370~395 (2016)
  76. Tessler FN, "ACR Thyroid Imaging, Reporting and Data System(TI-RADS) : white paper of the ACR TI-RADS Committee", J Am Coll Radiol, 14(5), pp.587~595 (2017)
  77. Russ G, "European Thyroid Association guidelines for ultrasound malignancy risk stratification of thyroid nodules in adults : the EU-TIRADS", Eur Thyroid J, 6(5), pp.225~237 (2017)
  78. Zhou J, "2020 Chinese guidelines for ultrasound malignancy risk stratification of thyroid nodules : the C-TIRADS", Endocrine, 70(2), pp.256~279 (2020)
  79. Moon WJ, "Benign and malignant thyroid nodules : US differentiation--multicenter retrospective study", Radiology, 247(3), pp.762~770 (2008)
  80. Brito JP, "The accuracy of thyroid nodule ultrasound to predict thyroid cancer : systematic review and meta-analysis", J Clin Endocrinol Metab, 99(4), pp.1253~1263 (2014)
  81. Campanella P, "Quantification of cancer risk of each clinical and ultrasonographic suspicious feature of thyroid nodules : a systematic review and meta-analysis", Eur J Endocrinol, 170(5), pp.R203~R211 (2014)
  82. Remonti LR, "Thyroid ultrasound features and risk of carcinoma : a systematic review and meta-analysis of observational studies", Thyroid, 25(5), pp.538~550 (2015)
  83. Na DG, "Thyroid Imaging Reporting and Data System risk stratification of thyroid nodules : categorization based on solidity and echogenicity", Thyroid, 26(4), pp.562~572 (2016)
  84. Sugitani I, "Indications and strategy for active surveillance of adult low-risk papillary thyroid microcarcinoma : consensus statements from the Japan Association of Endocrine Surgery Task Force on management for papillary thyroid microcarcinoma", Thyroid, 31(2), pp.183~192 (2021)
  85. Suzuki S, "Childhood and adolescent thyroid cancer in Fukushima after the Fukushima Daiichi Nuclear Power Plant Accident : 5 years on", Clin Oncol(R Coll Radiol), 28(4), pp.263~271 (2016)
  86. Chen W, "Evaluation of thyroid FDG uptake incidentally identified on FDG-PET", CT imaging, 2009, pp.30(3), 240~244
  87. Nishimori H, "Incidental thyroid"PETomas" : clinical significance and novel description of the self-resolving variant of focal FDG-PET thyroid uptake", Can J Surg, 54(2), pp.83~88 (2011)
  88. Soelberg KK, "Risk of malignancy in thyroid incidentalomas detected by 18F-fluorodeoxyglucose positron emission tomography : a systematic review", Thyroid, 22(9), pp.918~925 (2012)
  89. Chung SR, "Thyroid incidentalomas detected on(18)F-fluorodeoxyglucose positron emission tomography with computed tomography : malignant risk stratification and management plan", Thyroid, 28(6), pp.762~768 (2018)
  90. Felder GJ, "Risk stratification of(18)F-fluorodeoxyglucose-avid thyroid nodules based on ACR thyroid imaging reporting and data system", J Am Coll Radiol, 18(3 Pt A), pp.388~394 (2021)
  91. de Leijer JF, "Focal thyroid incidentalomas on(18)F-FDG PET", CT : a systematic review and meta-analysis on prevalence, risk of malignancy and inconclusive fine needle aspiration, 2021, pp.12, 723394~
  92. Ali SZ, "The Bethesda system for reporting thyroid cytopathology" (2010), Springer
  93. Ali SZ, "The Bethesda system for reporting thyroid cytopathology" (2018), Springer
  94. Ali SZ, "The 2023 Bethesda system for reporting thyroid cytopathology", J Am Soc Cytopathol, 12(5), pp.319~325 (2023)
  95. Valderrabano P, "Cancer risk associated with nuclear atypia in cytologically indeterminate thyroid nodules : a systematic review and meta-analysis", Thyroid, 28(2), pp.210~219 (2018)
  96. Joo L, "Comparison of core needle biopsy and repeat fine-needle aspiration in avoiding diagnostic surgery for thyroid nodules initially diagnosed as atypia", follicular lesion of undetermined significance, 2022, pp.23(2), 280~288
  97. Kim K, "Diagnostic performance of thyroid core needle biopsy using the revised reporting system : comparison with fine needle aspiration cytology", Endocrinol Metab(Seoul), 37(1), pp.159~169 (2022)
  98. Park JY, "Diagnostic efficacy, performance and safety of side-cut core needle biopsy for thyroid nodules : comparison of automated and semi-automated biopsy needles", Endocrine, 76(2), pp.341~348 (2022)
  99. Ahn HS, "Diagnostic performance of core needle biopsy as a first-line diagnostic tool for thyroid nodules according to ultrasound patterns : comparison with fine needle aspiration using propensity score matching analysis", Clin Endocrinol(Oxf), 94(3), pp.494~503 (2021)
  100. Son HM, "Distribution and malignancy risk of six categories of the pathology reporting system for thyroid core-needle biopsy in 1, 216 consecutive thyroid nodules", Ultrasonography, 39(2), pp.159~165 (2020)
  101. Chung SR, "Risk of malignancy according to the subclassification of atypia of undetermined significance and suspicious follicular neoplasm categories in thyroid core needle biopsies", Endocr Pathol, 30(2), pp.146~154 (2019)
  102. Na HY, "Preoperative diagnostic categories of noninvasive follicular thyroid neoplasm with papillary-like nuclear features in thyroid core needle biopsy and its impact on risk of malignancy", Endocr Pathol, 30(4), pp.329~339 (2019)
  103. Xiong Y, "Pathological diagnosis of thyroid nodules based on core needle biopsies : comparative study between core needle biopsies and resected specimens in 578 cases", Diagn Pathol, 14(1), pp.10~ (2019)
  104. Ahn HS, "Comparison of the diagnostic efficacy of ultrasound-guided core needle biopsy with 18-versus 20-gauge needles for thyroid nodules", J Ultrasound Med, 37(11), pp.2565~2574 (2018)
  105. Choe J, "Core needle biopsy of thyroid nodules : outcomes and safety from a large single-center single-operator study", Acta Radiol, 59(8), pp.924~931 (2018)
  106. Choe JY, "Utility of a formatted pathologic reporting system in thyroid core needle biopsy : a validation study of 1998consecutive cases", Clin Endocrinol(Oxf), 88(1), pp.96~104 (2018)
  107. Hong MJ, "Role of core needle biopsy as a first-line diagnostic tool for thyroid nodules : a retrospective cohort study", Ultrasonography, 37(3), pp.244~253 (2018)
  108. Chung SR, "Ultrasound-pathology discordant nodules on core-needle biopsy : malignancy risk and management strategy", Thyroid, 27(5), pp.707~713 (2017)
  109. Kim HC, "First-line use of core needle biopsy for high-yield preliminary diagnosis of thyroid nodules", AJNR Am J Neuroradiol, 38(2), pp.357~363 (2017)
  110. Suh CH, "Efficacy and safety of core-needle biopsy in initially detected thyroid nodules via propensity score analysis", Sci Rep, 7(1), pp.8242~ (2017)
  111. Suh CH, "The role of core-needle biopsy as a first-line diagnostic tool for initially detected thyroid nodules", Thyroid, 26(3), pp.395~403 (2016)
  112. Suh CH, "The role of core-needle biopsy in the diagnosis of thyroid malignancy in 4580 patients with 4746 thyroid nodules : a systematic review and meta-analysis", Endocrine, 54(2), pp.315~328 (2016)
  113. Kim YH, "Applying ultrasound-guided core needle biopsy for diagnosis of thyroid masses : preliminary results from a single institution", J Ultrasound Med, 34(10), pp.1801~1808 (2015)
  114. Ha EJ, "Core needle biopsy can minimise the non-diagnostic results and need for diagnostic surgery in patients with calcified thyroid nodules", Eur Radiol, 24(6), pp.1403~1409 (2014)
  115. Trimboli P, "The use of core needle biopsy as first-line in diagnosis of thyroid nodules reduces false negative and inconclusive data reported by fine-needle aspiration", World J Surg Oncol, 12, pp.61~ (2014)
  116. Ha EJ, "Sonographically suspicious thyroid nodules with initially benign cytologic results : the role of a core needle biopsy", Thyroid, 23(6), pp.703~708 (2013)
  117. Sung JY, "Diagnostic accuracy of fine-needle aspiration versus core-needle biopsy for the diagnosis of thyroid malignancy in a clinical cohort", Eur Radiol, 22(7), pp.1564~1572 (2012)
  118. Crothers BA, "The Bethesda system for reporting thyroid cytopathology", pp.7~18 (2018), Springer
  119. Wu HH, "The Bethesda system for reporting thyroid cytopathology : an experience of 1, 382 cases in a community practice setting with the implication for risk of neoplasm and risk of malignancy", Diagn Cytopathol, 40(5), pp.399~403 (2012)
  120. Layfield LJ, "Post-thyroid FNA testing and treatment options : a synopsis of the National Cancer Institute Thyroid Fine Needle Aspiration State of the Science Conference", Diagn Cytopathol, 36(6), pp.442~448 (2008)
  121. Singh RS, "Timing of repeat thyroid fine-needle aspiration in the management of thyroid nodules", Acta Cytol, 55(6), pp.544~548 (2011)
  122. Lubitz CC, "Diagnostic yield of nondiagnostic thyroid nodules is not altered by timing of repeat biopsy", Thyroid, 22(6), pp.590~594 (2012)
  123. Valerio E, "Should we wait 3months for a repeat aspiration in non-diagnostic", indeterminate thyroid nodules? A cancer centre experience, 2020, pp.31(6), 525~532
  124. Orija IB, "Value of repeating a nondiagnostic thyroid fine-needle aspiration biopsy", Endocr Pract, 13(7), pp.735~742 (2007)
  125. Alexander EK, "Assessment of nondiagnostic ultrasound-guided fine needle aspirations of thyroid nodules", J Clin Endocrinol Metab, 87(11), pp.4924~4927 (2002)
  126. Choi YS, "Clinical and ultrasonographic findings affecting nondiagnostic results upon the second fine needle aspiration for thyroid nodules", Ann Surg Oncol, 19(7), pp.2304~2309 (2012)
  127. Na DG, "Core-needle biopsy is more useful than repeat fine-needle aspiration in thyroid nodules read as nondiagnostic or atypia of undetermined significance by the Bethesda system for reporting thyroid cytopathology", Thyroid, 22(5), pp.468~475 (2012)
  128. Lee SH, "Clinical outcomes in patients with non-diagnostic thyroid fine needle aspiration cytology : usefulness of the thyroid core needle biopsy", Ann Surg Oncol, 21(6), pp.1870~1877 (2014)
  129. Choi SH, "Thyroid nodules with initially non-diagnostic, fine-needle aspiration results : comparison of core-needle biopsy and repeated fine-needle aspiration", Eur Radiol, 24(11), pp.2819~2826 (2014)
  130. Jung SM, "Comparison of core-needle biopsy and repeat fine-needle aspiration for thyroid nodules with inconclusive initial cytology", Eur Arch Otorhinolaryngol, 278(8), pp.3019~3025 (2021)
  131. Moon HJ, "How to manage thyroid nodules with two consecutive non-diagnostic results on ultrasonography-guided fine-needle aspiration", World J Surg, 36(3), pp.586~592 (2012)
  132. Vuong HG, "The use of the Bethesda system for reporting thyroid cytopathology in pediatric thyroid nodules : a meta-analysis", Thyroid, 31(8), pp.1203~1211 (2021)
  133. Vuong HG, "Differences in surgical resection rate and risk of malignancy in thyroid cytopathology practice between Western and Asian countries : a systematic review and meta-analysis", Cancer Cytopathol, 128(4), pp.238~249 (2020)
  134. Chehade JM, "Role of repeated fine-needle aspiration of thyroid nodules with benign cytologic features", Endocr Pract, 7(4), pp.237~243 (2001)
  135. Orlandi A, "Repeated fine-needle aspiration of the thyroid in benign nodular thyroid disease : critical evaluation of long-term follow-up", Thyroid, 15(3), pp.274~278 (2005)
  136. Oertel YC, "Value of repeated fine needle aspirations of the thyroid : an analysis of over ten thousand FNAs", Thyroid, 17(11), pp.1061~1066 (2007)
  137. Illouz F, "Usefulness of repeated fine-needle cytology in the follow-up of non-operated thyroid nodules", Eur J Endocrinol, 156(3), pp.303~308 (2007)
  138. Tee YY, "Fine-needle aspiration may miss a third of all malignancy in palpable thyroid nodules : a comprehensive literature review", Ann Surg, 246(5), pp.714~720 (2007)
  139. Pinchot SN, "Accuracy of fine-needle aspiration biopsy for predicting neoplasm or carcinoma in thyroid nodules 4 cm or larger", Arch Surg, 144(7), pp.649~655 (2009)
  140. Kuru B, "The false-negative rate of fine-needle aspiration cytology for diagnosing thyroid carcinoma in thyroid nodules", Langenbecks Arch Surg, 395(2), pp.127~132 (2010)
  141. Wharry LI, "Thyroid nodules(>", =4 cm) : can ultrasound and cytology reliably exclude cancer?, 2014, pp.38(3), 614~621
  142. Nou E, "Determination of the optimal time interval for repeat evaluation after a benign thyroid nodule aspiration", J Clin Endocrinol Metab, 99(2), pp.510~516 (2014)
  143. Yoon JH, "The diagnostic accuracy of ultrasound-guided fine-needle aspiration biopsy and the sonographic differences between benign and malignant thyroid nodules 3 cm or larger", Thyroid, 21(9), pp.993~1000 (2011)
  144. Porterfield JR Jr, "Reliability of benign fine needle aspiration cytology of large thyroid nodules", Surgery, 144(6), pp.963~968 (2008)
  145. Hong MJ, "Cytologyultrasonography risk-stratification scoring system based on fine-needle aspiration cytology and the Korean-Thyroid Imaging Reporting and Data System", Thyroid, 27(7), pp.953~959 (2017)
  146. Krane JF, "The Bethesda system for reporting thyroid cytopathology", pp.49~70 (2018), Springer
  147. Cibas ES, "A prospective assessment defining the limitations of thyroid nodule pathologic evaluation", Ann Intern Med, 159(5), pp.325~332 (2013)
  148. Davidov T, "Routine second-opinion cytopathology review of thyroid fine needle aspiration biopsies reduces diagnostic thyroidectomy", Surgery, 148(6), pp.1294~1299 (2010)
  149. Park KT, "Role of core needle biopsy and ultrasonographic finding in management of indeterminate thyroid nodules", Head Neck, 33(2), pp.160~165 (2011)
  150. Lee KH, "Atypia of undetermined significance in thyroid fine-needle aspiration cytology : prediction of malignancy by US and comparison of methods for further management", Ann Surg Oncol, 21(7), pp.2326~2331 (2014)
  151. Na DG, "Role of core needle biopsy in the management of atypia", follicular lesion of undetermined significance thyroid nodules : comparison with repeat fine-needle aspiration in subcategory nodules, 2015, pp.4(3), 189~196
  152. Kim SK, "Surgical results of thyroid nodules according to a management guideline based on the BRAF(V600E)mutation status", J Clin Endocrinol Metab, 96(3), pp.658~664 (2011)
  153. Adeniran AJ, "BRAF mutation testing of thyroid fine-needle aspiration specimens enhances the predictability of malignancy in thyroid follicular lesions of undetermined significance", Acta Cytol, 55(6), pp.570~575 (2011)
  154. Ngo HTT, "Impact of molecular testing on the management of indeterminate thyroid nodules among Western and Asian countries : a systematic review and meta-analysis", Endocr Pathol, 32(2), pp.269~279 (2021)
  155. Roth MY, "Molecular testing for thyroid nodules : review and current state", Cancer, 124(5), pp.888~898 (2018)
  156. Patel KN, "Performance of a genomic sequencing classifier for the preoperative diagnosis of cytologically indeterminate thyroid nodules", JAMA Surg, 153(9), pp.817~824 (2018)
  157. Steward DL, "Performance of a multigene genomic classifier in thyroid nodules with indeterminate cytology : a prospective blinded multicenter study", JAMA Oncol, 5(2), pp.204~212 (2019)
  158. Labourier E, "Molecular testing for miRNA, mRNA, and DNA on fine-needle aspiration improves the preoperative diagnosis of thyroid nodules with indeterminate cytology", J Clin Endocrinol Metab, 100(7), pp.2743~2750 (2015)
  159. Lithwick-Yanai G, "Multicentre validation of a microRNA-based assay for diagnosing indeterminate thyroid nodules utilising fine needle aspirate smears", J Clin Pathol, 70(6), pp.500~507 (2017)
  160. Agarwal S, "Emerging biomarkers in thyroid practice and research", Cancers(Basel), 14(1), pp.204~ (2021)
  161. Larcher de Almeida AM, "Combining the American Thyroid Association's ultrasound classification with cytological subcategorization improves the assessment of malignancy risk in indeterminate thyroid nodules", Thyroid, 31(6), pp.922~932 (2021)
  162. Słowińska-Klencka D, "Diagnostic value of six thyroid imaging reporting and data systems(TIRADS)in cytologically equivocal thyroid nodules", J Clin Med, 9(7), pp.2281~ (2020)
  163. Henry MR, "The Bethesda system for reporting thyroid cytopathology", pp.71~80 (2018), Springer
  164. Nikiforov YE, "Nomenclature revision for encapsulated follicular variant of papillary thyroid carcinoma : a paradigm shift to reduce overtreatment of indolent tumors", JAMA Oncol, 2(8), pp.1023~1029 (2016)
  165. Kuru B, "Risk factors associated with malignancy and with triage to surgery in thyroid nodules classified as Bethesda category IV(FN", SFN), 2018, pp.46(6), 489~494
  166. Parikh PP, "Surgeon-performed ultrasound predictors of malignancy in patients with Hurthle cell neoplasms of the thyroid", J Surg Res, 184(1), pp.247~252 (2013)
  167. Petric R, "Preoperative serum thyroglobulin concentration is an independent predictive factor of malignancy in follicular neoplasms of the thyroid gland", J Surg Oncol, 105(4), pp.351~356 (2012)
  168. Lubitz CC, "Clinical and cytological features predictive of malignancy in thyroid follicular neoplasms", Thyroid, 20(1), pp.25~31 (2010)
  169. Williams MD, "Clinical significance of distinguishing between follicular lesion and follicular neoplasm in thyroid fine-needle aspiration biopsy", Ann Surg Oncol, 16(11), pp.3146~3153 (2009)
  170. Choi YJ, "Clinical and ultrasound features of cytology diagnosed follicular neoplasm", Endocr J, 56(3), pp.383~389 (2009)
  171. Gulcelik NE, "Risk of malignancy in patients with follicular neoplasm : predictive value of clinical and ultrasonographic features", Arch Otolaryngol Head Neck Surg, 134(12), pp.1312~1315 (2008)
  172. Raber W, "Risk factors for malignancy of thyroid nodules initially identified as follicular neoplasia by fine-needle aspiration : results of a prospective study of one hundred twenty patients", Thyroid, 10(8), pp.709~712 (2000)
  173. Tuttle RM, "Clinical features associated with an increased risk of thyroid malignancy in patients with follicular neoplasia by fine-needle aspiration", Thyroid, 8(5), pp.377~383 (1998)
  174. Baloch ZW, "Diagnosis of"follicular neoplasm" : a gray zone in thyroid fine-needle aspiration cytology", Diagn Cytopathol, 26(1), pp.41~44 (2002)
  175. Kim HJ, "Preoperative serum thyroglobulin and changes in serum thyroglobulin during TSH suppression independently predict follicular thyroid carcinoma in thyroid nodules with a cytological diagnosis of follicular lesion", Endocr Res, 42(2), pp.154~162 (2017)
  176. Giorgadze T, "Does the fine-needle aspiration diagnosis of"Hurthle-cell neoplasm", follicular neoplasm with oncocytic features"denote increased risk of malignancy?, 2004, pp.31(5), 307~312
  177. Raparia K, "Clinical outcomes for"suspicious"category in thyroid fine-needle aspiration biopsy : patient's sex and nodule size are possible predictors of malignancy", Arch Pathol Lab Med, 133(5), pp.787~790 (2009)
  178. Durante C, "2023 European Thyroid Association clinical practice guidelines for thyroid nodule management", Eur Thyroid J, 12(5), pp.e230067~ (2023)
  179. Cho YY, "Malignancy risk of follicular neoplasm(Bethesda IV)with variable cutoffs of tumor size : a systemic review and meta-analysis", J Clin Endocrinol Metab, 109(5), pp.1383~1392 (2024)
  180. Ali SZ, "The 2023 Bethesda system for reporting thyroid cytopathology", Thyroid, 33(9), pp.1039~1044 (2023)
  181. Lasolle H, "SFE-AFCE-SFMN 2022 consensus on the management of thyroid nodules : role of molecular tests for cytologically indeterminate thyroid nodules", Ann Endocrinol(Paris), 83(6), pp.395~400 (2022)
  182. Hu TX, "The effect modification of ultrasound risk classification on molecular testing in predicting the risk of malignancy in cytologically indeterminate thyroid nodules", Thyroid, 32(8), pp.905~916 (2022)
  183. Stewardson P, "Diagnosis of endocrine disease : usefulness of genetic testing of fine-needle aspirations for diagnosis of thyroid cancer", Eur J Endocrinol, 187(3), pp.R41~R52 (2022)
  184. Colombo C, "The thyroid risk score(TRS)for nodules with indeterminate cytology", Endocr Relat Cancer, 28(4), pp.225~235 (2021)
  185. VanderLaan PA, "The Bethesda system for reporting thyroid cytopathology", pp.101~118 (2018), Springer
  186. Chen B, "The predictive value of coexisting BRAFV600E and TERT promoter mutations on poor outcomes and high tumour aggressiveness in papillary thyroid carcinoma : a systematic review and meta-analysis", Clin Endocrinol(Oxf), 94(5), pp.731~742 (2021)
  187. Moon S, "Effects of coexistent BRAF(V600E)and TERT promoter mutations on poor clinical outcomes in papillary thyroid cancer : a meta-analysis", Thyroid, 27(5), pp.651~660 (2017)
  188. Ha EJ, "Primary imaging test and appropriate biopsy methods for thyroid nodules : guidelines by Korean Society of Radiology and National Evidence-based Healthcare Collaborating Agency", Korean J Radiol, 19(4), pp.623~631 (2018)
  189. Ito Y, "An observational trial for papillary thyroid microcarcinoma in Japanese patients", World J Surg, 34(1), pp.28~35 (2010)
  190. Molinaro E, "Active surveillance in papillary thyroid microcarcinomas is feasible and safe : experience at a single Italian center", J Clin Endocrinol Metab, 105(3), pp.e172~e180 (2020)
  191. Sanabria A, "Experience with active surveillance of thyroid low-risk carcinoma in a developing country", Thyroid, 30(7), pp.985~991 (2020)
  192. Jin M, "Tumor volume doubling time in active surveillance of papillary thyroid microcarcinoma : a multicenter cohort study in Korea", Thyroid, 31(10), pp.1494~1501 (2021)
  193. Nagaoka R, "Multifocality and progression of papillary thyroid microcarcinoma during active surveillance", World J Surg, 45(9), pp.2769~2776 (2021)
  194. Ho AS, "Expanded parameters in active surveillance for low-risk papillary thyroid carcinoma : a nonrandomized controlled trial", JAMA Oncol, 8(11), pp.1588~1596 (2022)
  195. Lee EK, "Progression of low-risk papillary thyroid microcarcinoma during active surveillance : interim analysis of a multicenter prospective cohort study of active surveillance on papillary thyroid microcarcinoma in Korea", Thyroid, 32(11), pp.1328~1336 (2022)
  196. Ito Y, "Thyroid-stimulating hormone, age, and tumor size are risk factors for progression during active surveillance of low-risk papillary thyroid microcarcinoma in adults", World J Surg, 47(2), pp.392~401 (2023)
  197. Miyauchi A, "Long-term outcomes of active surveillance and immediate surgery for adult patients with low-risk papillary thyroid microcarcinoma : 30-year experience", Thyroid, 33(7), pp.817~825 (2023)
  198. Tuttle RM, "Active surveillance of papillary thyroid cancer : frequency and time course of the six most common tumor volume kinetic patterns", Thyroid, 32(11), pp.1337~1345 (2022)
  199. Oh HS, "Tumor volume doubling time in active surveillance of papillary thyroid carcinoma", Thyroid, 29(5), pp.642~649 (2019)
  200. Lee JY, "US predictors of papillary thyroid microcarcinoma progression at active surveillance", Radiology, 309(1), pp.e230006~ (2023)
  201. Ito Y, "Patient age is significantly related to the progression of papillary microcarcinoma of the thyroid under observation", Thyroid, 24(1), pp.27~34 (2014)
  202. Mazzaferri EL, "Approach to the pregnant patient with thyroid cancer", J Clin Endocrinol Metab, 96(2), pp.265~272 (2011)
  203. Oh HS, "Serial neck ultrasonographic evaluation of changes in papillary thyroid carcinoma during pregnancy", Thyroid, 27(6), pp.773~777 (2017)
  204. Ito Y, "Effects of pregnancy on papillary microcarcinomas of the thyroid re-evaluated in the entire patient series at Kuma Hospital", Thyroid, 26(1), pp.156~160 (2016)
  205. Horiguchi K, "Position paper from the Japan Thyroid Association task force on the management of low-risk papillary thyroid microcarcinoma(T1aN0M0)in adults", Endocr J, 68(7), pp.763~780 (2021)
  206. Hwang H, "Surgical outcomes in patients with low-risk papillary thyroid microcarcinoma from MAeSTro study : immediate operation versus delayed operation after active surveillance : a multicenter prospective cohort study", Ann Surg, 278(5), pp.e1087~e1095 (2023)
  207. Kim K, "Active surveillance versus immediate surgery for low-risk papillary thyroid microcarcinoma patients in South Korea : a cost-minimization analysis from the MAeSTro study", Thyroid, 32(6), pp.648~656 (2022)
  208. Baek HS, "Cost-effectiveness of active surveillance compared to early surgery of small papillary thyroid cancer : a retrospective study on a Korean population", J Korean Med Sci, 38(34), pp.e264~ (2023)
  209. Kong SH, "Longitudinal assessment of quality of life according to treatment options in low-risk papillary thyroid microcarcinoma patients : active surveillance or immediate surgery(interim analysis of MAeSTro)", Thyroid, 29(8), pp.1089~1096 (2019)
  210. Moon JH, "Effect of initial treatment choice on 2-year quality of life in patients with low-risk papillary thyroid microcarcinoma", J Clin Endocrinol Metab, 106(3), pp.724~735 (2021)
  211. Hwangbo Y, "A cross-sectional survey of patient treatment choice in a multicenter prospective cohort study on active surveillance of papillary thyroid microcarcinoma(MAeSTro)", Thyroid, 32(7), pp.772~780 (2022)
  212. Brito JP, "Thyroid cancer treatment choice : a pilot study of a tool to facilitate conversations with patients with papillary microcarcinomas considering treatment options", Thyroid, 28(10), pp.1325~1331 (2018)
  213. Goldner WS, "Molecular variants and their risks for malignancy in cytologically indeterminate thyroid nodules", Thyroid, 29(11), pp.1594~1605 (2019)
  214. Gilani SM, "RAS mutation and associated risk of malignancy in the thyroid gland : an FNA study with cytology-histology correlation", Cancer Cytopathol, 130(4), pp.284~293 (2022)
  215. Yang J, "Association between TERT promoter mutations and clinical behaviors in differentiated thyroid carcinoma : a systematic review and meta-analysis", Endocrine, 67(1), pp.44~57 (2020)
  216. Shonka DC Jr, "American Head and Neck Society Endocrine Surgery Section and International Thyroid Oncology Group consensus statement on mutational testing in thyroid cancer : defining advanced thyroid cancer and its targeted treatment", Head Neck, 44(6), pp.1277~1300 (2022)
  217. Kim SY, "Frequency of TERT promoter mutations in real-world analysis of 2, 092 thyroid carcinoma patients(Endocrinol Metab 2022;37 : 652-63, Heera Yang et al. )", Endocrinol Metab(Seoul), 37(6), pp.947~948 (2022)
  218. Yang H, "Frequency of TERT promoter mutations in real-world analysis of 2, 092 thyroid carcinoma patients", Endocrinol Metab(Seoul), 37(4), pp.652~663 (2022)
  219. Kim SY, "Highly prevalent BRAF V600E and low-frequency TERT promoter mutations underlie papillary thyroid carcinoma in Koreans", J Pathol Transl Med, 54(4), pp.310~317 (2020)
  220. Choi YS, "Prospective analysis of TERT promoter mutations in papillary thyroid carcinoma at a single institution", J Clin Med, 10(10), pp.2179~ (2021)
  221. Lee J, "Presence of TERT +", -BRAF V600E mutation is not a risk factor for the clinical management of patients with papillary thyroid microcarcinoma, 2021, pp.170(3), 743~747
  222. Wang N, "Is fluorine-18 fluorodeoxyglucose positron emission tomography useful for the thyroid nodules with indeterminate fine needle aspiration biopsy? A metaanalysis of the literature", J Otolaryngol Head Neck Surg, 42(1), pp.38~ (2013)
  223. Vriens D, "Cost-effectiveness of FDG-PET", CT for cytologically indeterminate thyroid nodules : a decision analytic approach, 2014, pp.99(9), 3263~3274
  224. Deandreis D, "Is(18)F-fluorodeoxyglucose-PET", CT useful for the presurgical characterization of thyroid nodules with indeterminate fine needle aspiration cytology?, 2012, pp.22(2), 165~172
  225. FDG-PET, "CT to prevent futile surgery in indeterminate thyroid nodules : a blinded, randomised controlled multicentre trial", Eur J Nucl Med Mol Imaging, 49(6), pp.1970~1984 (2022)
  226. de Koster EJ, "FDG-PET", CT in indeterminate thyroid nodules : cost-utility analysis alongside a randomised controlled trial, 2022, pp.49(10), 3452~3469
  227. Papini E, "Risk of malignancy in nonpalpable thyroid nodules : predictive value of ultrasound and color-Doppler features", J Clin Endocrinol Metab, 87(5), pp.1941~1946 (2002)
  228. Brito JP, "Prevalence of thyroid cancer in multinodular goiter versus single nodule : a systematic review and metaanalysis", Thyroid, 23(4), pp.449~455 (2013)
  229. Leenhardt L, "Indications and limits of ultrasound-guided cytology in the management of nonpalpable thyroid nodules", J Clin Endocrinol Metab, 84(1), pp.24~28 (1999)
  230. Baser H, "Are cytologic and histopathologic features of hot thyroid nodules different from cold thyroid nodules?", Diagn Cytopathol, 47(9), pp.898~903 (2019)
  231. Carmeci C, "Ultrasound-guided fine-needle aspiration biopsy of thyroid masses", Thyroid, 8(4), pp.283~289 (1998)
  232. Ylagan LR, "Fine needle aspiration of the thyroid : a cytohistologic correlation and study of discrepant cases", Thyroid, 14(1), pp.35~41 (2004)
  233. Alexander EK, "Natural history of benign solid and cystic thyroid nodules", Ann Intern Med, 138(4), pp.315~318 (2003)
  234. Brander AE, "Importance of thyroid abnormalities detected at US screening : a 5-year follow-up", Radiology, 215(3), pp.801~806 (2000)
  235. Erdogan MF, "Value of re-aspirations in benign nodular thyroid disease", Thyroid, 8(12), pp.1087~1090 (1998)
  236. Danese D, "Diagnostic accuracy of conventional versus sonography-guided fine-needle aspiration biopsy of thyroid nodules", Thyroid, 8(1), pp.15~21 (1998)
  237. Rosario PW, "What is the best criterion for repetition of fine-needle aspiration in thyroid nodules with initially benign cytology?", Thyroid, 25(10), pp.1115~1120 (2015)
  238. Maino F, "Validation of American Thyroid Association ultrasound risk-adapted approach for repeating cytology in benign thyroid nodules", Thyroid, 31(3), pp.446~451 (2021)
  239. Kim SY, "Thyroid nodules with benign findings at cytologic examination : results of long-term follow-up with US", Radiology, 271(1), pp.272~281 (2014)
  240. Zhang M, "Thyroid nodules with suspicious ultrasound findings : the role of ultrasoundguided core needle biopsy", Clin Imaging, 38(4), pp.434~438 (2014)
  241. Chung SR, "The role of core needle biopsy for the evaluation of thyroid nodules with suspicious ultrasound features", Korean J Radiol, 20(1), pp.158~165 (2019)
  242. Durante C, "The natural history of benign thyroid nodules", JAMA, 313(9), pp.926~935 (2015)
  243. Papini E, "Long-term changes in nodular goiter : a 5-year prospective randomized trial of levothyroxine suppressive therapy for benign cold thyroid nodules", J Clin Endocrinol Metab, 83(3), pp.780~783 (1998)
  244. Zelmanovitz F, "Suppressive therapy with levothyroxine for solitary thyroid nodules : a double-blind controlled clinical study and cumulative meta-analyses", J Clin Endocrinol Metab, 83(11), pp.3881~3885 (1998)
  245. Wemeau JL, "Effects of thyroid-stimulating hormone suppression with levothyroxine in reducing the volume of solitary thyroid nodules and improving extranodular nonpalpable changes : a randomized, double-blind, placebo-controlled trial by the French Thyroid Research Group", J Clin Endocrinol Metab, 87(11), pp.4928~4934 (2002)
  246. Castro MR, "Effectiveness of thyroid hormone suppressive therapy in benign solitary thyroid nodules : a meta-analysis", J Clin Endocrinol Metab, 87(9), pp.4154~4159 (2002)
  247. Ha EJ, "Radiofrequency ablation of benign thyroid nodules : recommendations from the Asian Conference on Tumor Ablation Task Force", Ultrasonography, 40(1), pp.75~82 (2021)
  248. Papini E, "2020European Thyroid Association clinical practice guideline for the use of image-guided ablation in benign thyroid nodules", Eur Thyroid J, 9(4), pp.172~185 (2020)
  249. Kuo JH, "A comprehensive review of interventional ablation techniques for the management of thyroid nodules and metastatic lymph nodes", Surgery, 171(4), pp.920~931 (2022)
  250. Guan SH, "Comparison of ultrasoundguided thermal ablation and conventional thyroidectomy for benign thyroid nodules : a systematic review and meta-analysis", Int J Hyperthermia, 37(1), pp.442~449 (2020)
  251. Jin H, "Conventional thyroidectomy vs thyroid thermal ablation on postoperative quality of life and satisfaction for patients with benign thyroid nodules", Eur J Endocrinol, 184(1), pp.131~141 (2021)
  252. Hahn SY, "Ethanol ablation of the thyroid nodules : 2018 consensus statement by the Korean Society of Thyroid Radiology", Korean J Radiol, 20(4), pp.609~620 (2019)
  253. Bandeira-Echtler E, "Levothyroxine or minimally invasive therapies for benign thyroid nodules", Cochrane Database Syst Rev, 2014(6), pp.CD004098~ (2014)
  254. Chung SR, "The role of core needle biopsy in the diagnosis of initially detected thyroid nodules : a systematic review and meta-analysis", Eur Radiol, 28(11), pp.4909~4918 (2018)
  255. Park KW, "Ultrasound-guided fine-needle aspiration or core needle biopsy for diagnosing follicular thyroid carcinoma?", Clin Endocrinol(Oxf), 92(5), pp.468~474 (2020)
  256. Na HY, "Preoperative diagnostic categories of fine needle aspiration cytology for histologically proven thyroid follicular adenoma and carcinoma, and Hurthle cell adenoma and carcinoma : analysis of cause of under-or misdiagnoses", PLoS One, 15(11), pp.e0241597~ (2020)
  257. Kwak JY, "Value of US correlation of a thyroid nodule with initially benign cytologic results", Radiology, 254(1), pp.292~300 (2010)
  258. Yang J, "Fine-needle aspiration of thyroid nodules : a study of 4703 patients with histologic and clinical correlations", Cancer, 111(5), pp.306~315 (2007)
  259. Gerhard R, "Inter-and intraobserver reproducibility of thyroid fine needle aspiration cytology : an analysis of discrepant cases", Cytopathology, 18(2), pp.105~111 (2007)
  260. Scappaticcio L, "Repeat thyroid FNAC : inter-observer agreement among high-and low-volume centers in Naples metropolitan area and correlation with the EU-TIRADS", Front Endocrinol(Lausanne), 13, pp.1001728~ (2022)
  261. Jung SL, "Efficacy and safety of radiofrequency ablation for benign thyroid nodules : a prospective multicenter study", Korean J Radiol, 19(1), pp.167~174 (2018)
  262. Baek JH, "Radiofrequency versus ethanol ablation for treating predominantly cystic thyroid nodules : a randomized clinical trial", Korean J Radiol, 16(6), pp.1332~1340 (2015)
  263. Sung JY, "Single-session treatment of benign cystic thyroid nodules with ethanol versus radiofrequency ablation : a prospective randomized study", Radiology, 269(1), pp.293~300 (2013)
  264. Choi WJ, "Management of cystic or predominantly cystic thyroid nodules : role of simple aspiration of internal fluid", Endocr Res, 40(4), pp.215~219 (2015)
  265. Kim JH, "Efficacy of sonographically guided percutaneous ethanol injection for treatment of thyroid cysts versus solid thyroid nodules", AJR Am J Roentgenol, 180(6), pp.1723~1726 (2003)
  266. Jang SW, "How to manage the patients with unsatisfactory results after ethanol ablation for thyroid nodules : role of radiofrequency ablation", Eur J Radiol, 81(5), pp.905~910 (2012)
  267. Sung JY, "Optimum first-line treatment technique for benign cystic thyroid nodules : ethanol ablation or radiofrequency ablation?", AJR Am J Roentgenol, 196(2), pp.W210~W214 (2011)
  268. Lee JH, "Radiofrequency ablation(RFA)of benign thyroid nodules in patients with incompletely resolved clinical problems after ethanol ablation(EA)", World J Surg, 34(7), pp.1488~1493 (2010)
  269. Ahmad T, "Outcome of radioactive iodine therapy in toxic nodular goiter in Pakistan", Pak J Med Sci, 34(5), pp.1146~1151 (2018)
  270. Tzavara I, "Long term thyroid function after(131)I treatment for toxic adenoma", Hormones(Athens), 1(2), pp.99~103 (2002)
  271. Bawand R, "Comparison of clinical efficacy of antithyroid drugs, radioactive iodine, and thyroidectomy for treatment of patients with graves'disease, toxic thyroid adenoma, and toxic multinodular goiter", Biomed Biotechnol Res J, 6(4), pp.569~575 (2022)
  272. Ben Hamou A, "SFE-AFCE-SFMN 2022consensus on the management of thyroid nodules : thermal ablation", Ann Endocrinol(Paris), 83(6), pp.423~430 (2022)
  273. Demir BK, "Predictors of hypothyroidism following empirical dose radioiodine in toxic thyroid nodules : real-life experience", Endocr Pract, 28(8), pp.749~753 (2022)
  274. Roque C, "Long-term effects of radioiodine in toxic multinodular goiter : thyroid volume, function, and autoimmunity", J Clin Endocrinol Metab, 105(7), pp.dgaa214~ (2020)
  275. McDermott MT, "Hyperthyroidism", Ann Intern Med, 172(7), pp.ITC49~ITC64 (2020)
  276. Ross DS, "2016 American Thyroid Association guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis", Thyroid, 26(10), pp.1343~1421 (2016)
  277. Dobnig H, "Value of monopolar and bipolar radiofrequency ablation for the treatment of benign thyroid nodules", Best Pract Res Clin Endocrinol Metab, 33(4), pp.101283~ (2019)
  278. Kim HJ, "Efficacy and safety of thermal ablation for autonomously functioning thyroid nodules : a systematic review and meta-analysis", Eur Radiol, 31(2), pp.605~615 (2021)
  279. Mauri G, "Image-guided thermal ablation in autonomously functioning thyroid nodules. A retrospective multicenter threeyear follow-up study from the Italian minimally invasive treatment of the thyroid(MITT)group", Eur Radiol, 32(3), pp.1738~1746 (2022)
  280. Cesareo R, "Radiofrequency ablation on autonomously functioning thyroid nodules : a critical appraisal and review of the literature", Front Endocrinol(Lausanne), 11, pp.317~ (2020)
  281. Marley EF, "Fine-needle aspiration of thyroid lesions in 57 pregnant and postpartum women", Diagn Cytopathol, 16(2), pp.122~125 (1997)
  282. Kung AW, "The effect of pregnancy on thyroid nodule formation", J Clin Endocrinol Metab, 87(3), pp.1010~1014 (2002)
  283. Alexander EK, "2017 guidelines of the American Thyroid Association for the diagnosis and management of thyroid disease during pregnancy and the postpartum", Thyroid, 27(3), pp.315~389 (2017)
  284. Mestman JH, "Thyroid disorders of pregnancy", Endocrinol Metab Clin North Am, 24(1), pp.41~71 (1995)
  285. Herzon FS, "Coexistent thyroid cancer and pregnancy", Arch Otolaryngol Head Neck Surg, 120(11), pp.1191~1193 (1994)
  286. Moosa M, "Outcome of differentiated thyroid cancer diagnosed in pregnant women", J Clin Endocrinol Metab, 82(9), pp.2862~2866 (1997)
  287. Mazzaferri EL, "Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer", Am J Med, 97(5), pp.418~428 (1994)

관련 논문AI추천

2023 대한갑상선학회 갑상선결절 진료 권고안강수환, 강호철, 구본석, 김선욱, 김원배, 나동규, 박도준, 박영주, 백승국, 송영신, 오소원, 이가희, 이민경, 이상우, 이영아, 이용상, 이은경, 이지예, 임동준, 정유석, 정윤재, 정찬권, 조윤영, 주리히대한갑상선학회 · International Journal of Thyroidology2023 · 제16권 제1호대한갑상선학회 갑상선분화암 진료권고안 2024 어떻게 바뀌었나: 진단부터 초기치료까지이은경대한갑상선학회 · International Journal of Thyroidology2024 · 제17권 제2호대한갑상선학회 갑상선분화암 진료권고안; 개요 및 요약 2024강호철, 구본석, 권형주, 김근영, 김미진, 김보현, 김선욱, 김원구, 김원배, 김원웅, 김정한, 김희경, 나동규, 나희영, 문신제, 문정은, 박도준, 박소현, 박영주, 박준욱, 방지인, 백교림, 서영덕, 송영신, 신동엽, 신수진, 안화영, 오소원, 우승훈, 원호륜, 유창환, 윤지희, 이가희, 이민경, 이상우, 이승은, 이시훈, 이영아, 이은경, 이준협, 이지예, 이지은, 이초록, 임동준, 임재열, 전윤경, 정경연, 정아리, 정웅윤, 정윤재, 정찬권, 조관훈, 조윤영, 홍아람, 홍채문대한갑상선학회 · International Journal of Thyroidology2024 · 제17권 제1호대한갑상선학회 갑상선분화암 진료권고안; Part II. 갑상선분화암의 추적 2024강호철, 김미진, 김보현, 김선욱, 나동규, 박영주, 방지인, 서영덕, 송영신, 오소원, 이민경, 이상우, 이은경, 이지예, 임동준, 정아리, 정윤재, 홍채문대한갑상선학회 · International Journal of Thyroidology2024 · 제17권 제1호대한갑상선학회 갑상선분화암 진료권고안; Part IV. 임신 중 갑상선암의 치료 2024강호철, 김미진, 김보현, 김선욱, 김원구, 김희경, 나동규, 박영주, 송영신, 신동엽, 안화영, 윤지희, 이은경, 임동준, 정윤재, 조관훈, 조윤영, 홍아람대한갑상선학회 · International Journal of Thyroidology2024 · 제17권 제1호대한갑상선학회 갑상선분화암 진료권고안; Part I. 갑상선분화암의 초기치료 - 제2장 갑상선분화암의 적절한 초기 수술 2024강호철, 구본석, 권형주, 김선욱, 김원웅, 김정한, 김희경, 나동규, 박영주, 박준욱, 백교림, 송영신, 우승훈, 원호륜, 유창환, 윤지희, 이민경, 이은경, 이준협, 이지예, 이초록, 임동준, 임재열, 정윤재, 정찬권, 조윤영대한갑상선학회 · International Journal of Thyroidology2024 · 제17권 제1호

이 간행물의 다른 논문 (16건)

대한갑상선학회 갑상선분화암 진료권고안; 개요 및 요약 2024조윤영, 이승은, 박소현, 이상우, 이준협, 이지예, 이지은, 김희경, 이은경, 이민경, 김미진, 김선욱, 김정한, 정경연, 강호철, 임동준, 서영덕, 김원구, 이시훈, 문정은, 신수진, 김원배, 윤지희, 오소원, 송영신, 이가희, 임재열, 전윤경, 신동엽, 정윤재, 나동규, 김근영, 이영아, 김보현, 방지인, 조관훈, 박영주, 홍채문, 문신제, 홍아람, 백교림, 정웅윤, 정아리, 원호륜, 권형주, 나희영, 이초록, 우승훈, 박도준, 유창환, 정찬권, 박준욱, 김원웅, 구본석, 안화영pp. 1-20대한갑상선학회 갑상선분화암 진료권고안; Part I. 갑상선분화암의 초기치료 - 제1장 갑상선분화암의 수술 전 병기를 예측하기 위한 영상 및 혈액 검사 2024김선욱, 이민경, 박영주, 이은경, 이상우, 나동규, 정윤재, 송영신, 임동준, 강호철, 이지예, 조관훈, 방지인pp. 21-29대한갑상선학회 갑상선분화암 진료권고안; Part I. 갑상선분화암의 초기치료 - 제2장 갑상선분화암의 적절한 초기 수술 2024조윤영, 김정한, 김선욱, 이민경, 박영주, 이은경, 김희경, 이지예, 이준협, 나동규, 정윤재, 임재열, 송영신, 윤지희, 임동준, 강호철, 구본석, 김원웅, 박준욱, 정찬권, 유창환, 우승훈, 이초록, 권형주, 원호륜, 백교림pp. 30-52대한갑상선학회 갑상선분화암 진료권고안; Part I. 갑상선분화암의 초기치료 - 제3장 갑상선분화암의 수술 전후 합병증 평가 2024김선욱, 박영주, 이시훈, 유창환, 홍아람, 원호륜, 우승훈, 박준욱, 구본석, 강호철, 임동준, 이은경, 나동규, 정윤재, 전윤경, 임재열, 송영신pp. 53-60대한갑상선학회 갑상선분화암 진료권고안; Part I. 갑상선분화암의 초기치료 - 제4장 갑상선분화암의 수술 후 병리학적 진단 및 병기 결정 2024김선욱, 신수진, 나희영, 정찬권, 강호철, 임동준, 송영신, 정윤재, 나동규, 이은경, 박영주pp. 61-67